Variant report
Variant | esv3334517 |
---|---|
Chromosome Location | chr2:186398607-186403405 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:186378260..186381061-chr2:186398766..186401353,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558941848 | chr2:186398638-186398639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115035225 | chr2:186398641-186398642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185057133 | chr2:186398660-186398661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78643620 | chr2:186398710-186398711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544632263 | chr2:186398715-186398716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189331722 | chr2:186398752-186398753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs578250700 | chr2:186398779-186398780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545673091 | chr2:186398816-186398817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560755779 | chr2:186398853-186398854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139552326 | chr2:186398855-186398856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181749001 | chr2:186398891-186398892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185229450 | chr2:186398894-186398895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188145643 | chr2:186398923-186398924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144471168 | chr2:186398940-186398941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371272257 | chr2:186399010-186399011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568475446 | chr2:186399019-186399020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532757013 | chr2:186399033-186399034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551309660 | chr2:186399067-186399068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566739592 | chr2:186399071-186399072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369479067 | chr2:186399147-186399148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143362887 | chr2:186399152-186399153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146642216 | chr2:186399173-186399174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181387417 | chr2:186399174-186399175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186452378 | chr2:186399180-186399181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538295509 | chr2:186399204-186399205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556605787 | chr2:186399237-186399238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141326602 | chr2:186399241-186399242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191051394 | chr2:186399242-186399243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10195916 | chr2:186399254-186399255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183763613 | chr2:186399257-186399258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143348319 | chr2:186399275-186399276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564833226 | chr2:186399304-186399305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10206949 | chr2:186399312-186399313 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs528992522 | chr2:186399337-186399338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185919878 | chr2:186399340-186399341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191080535 | chr2:186399351-186399352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10196025 | chr2:186399355-186399356 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs550947397 | chr2:186399356-186399357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376077430 | chr2:186399370-186399371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566667427 | chr2:186399382-186399383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562653243 | chr2:186399416-186399417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527553144 | chr2:186399459-186399460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548908385 | chr2:186399498-186399499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183347615 | chr2:186399502-186399503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186891089 | chr2:186399532-186399533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12619952 | chr2:186399533-186399534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538026727 | chr2:186399602-186399603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372814845 | chr2:186399651-186399652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550342222 | chr2:186399663-186399664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571746873 | chr2:186399688-186399689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186381400-186432400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:186394400-186402200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr2:186398600-186402200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr2:186400600-186405200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:186401600-186402000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr2:186402000-186403200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr2:186402200-186403000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr2:186402200-186405200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr2:186402200-186405200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr2:186402400-186402800 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr2:186402400-186405000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr2:186402600-186404000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr2:186402600-186404200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:186403000-186403200 | Enhancers | H9 Cell Line | embryonic stem cell |
15 | chr2:186403000-186403400 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr2:186403000-186403400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
17 | chr2:186403200-186403400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr2:186403200-186406600 | Weak transcription | H9 Cell Line | embryonic stem cell |